Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening

Discovery of new butyrylcholinesterase inhibitors via structure-based virtual screening

Butyrylcholinesterase (BChE) plays an important role in the progression of the Alzheimer’s disease. In this study, we used a structure-based virtual screening (VS) approach to discover new BChE inhibitors. A ligand database was filtered and docked to the BChE protein using Glide program. The outcome...

Full description

Bibliographic Details
Main Authors:	Noor Atatreh, Sara Al Rawashdah, Shaikha S. Al Neyadi, Sawsan M. Abuhamdah, Mohammad A. Ghattas
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2019-01-01
Series:	Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:	butyrylcholinesterase inhibitors alzheimer’s disease ellman’s method virtual screening docking pharmacophore
Online Access:	http://dx.doi.org/10.1080/14756366.2019.1644329

Similar Items

Identification of new inhibitors of Mdm2–p53 interaction via pharmacophore and structure-based virtual screening
by: Atatreh N, et al.
Published: (2018-11-01)

Amaryllidaceae Alkaloids of Norbelladine-Type as Inspiration for Development of Highly Selective Butyrylcholinesterase Inhibitors: Synthesis, Biological Activity Evaluation, and Docking Studies
by: Abdullah Al Mamun, et al.
Published: (2021-08-01)

Method Development for Extraction of Butyrylcholin- esterase using Protein-G Agarose Spin Columns
by: Amruta S. Indapurkar, et al.
Published: (2015-01-01)

Discovery of Novel Focal Adhesion Kinase Inhibitors Using a Hybrid Protocol of Virtual Screening Approach Based on Multicomplex-Based Pharmacophore and Molecular Docking
by: Xiangrong Song, et al.
Published: (2012-11-01)

Selection of Efficient Inhibitors for Caspas-9 according to Structure-Based Pharmacophore Screening Strategy and Molecular Dynamics Simulations
by: Samira Ansari, et al.
Published: (2020-01-01)

Inhibition of acetylcholinesterase and butyrylcholinesterase with uracil derivatives: kinetic and computational studies
by: Huseyin Cavdar, et al.
Published: (2019-01-01)

The role of butyrylcholinesterase in the pathogenesis of Alzheimer's disease
by: Hao WU, et al.
Published: (2017-12-01)

2-(2-(4-Benzoylpiperazin-1-yl)ethyl)isoindoline-1,3-dione derivatives: Synthesis, docking and acetylcholinesterase inhibitory evaluation as anti-alzheimer agents
by: Ahmad Mohammadi-Farani, et al.
Published: (2017-01-01)

Combination of Virtual Screening Protocol by in Silico toward the Discovery of Novel 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors
by: Ying Fu, et al.
Published: (2018-02-01)

Structure-Based Virtual Screening of <i>Pseudomonas aeruginosa</i> LpxA Inhibitors using Pharmacophore-Based Approach
by: Baki Vijaya Bhaskar, et al.
Published: (2020-02-01)

Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase
by: Dong-mei Wang, et al.
Published: (2017-01-01)

Novel Hybrid Virtual Screening Protocol Based on Molecular Docking and Structure-Based Pharmacophore for Discovery of Methionyl-tRNA Synthetase Inhibitors as Antibacterial Agents
by: Cheng Peng, et al.
Published: (2013-07-01)

Discovery of Selective Butyrylcholinesterase (BChE) Inhibitors through a Combination of Computational Studies and Biological Evaluations
by: You Zhou, et al.
Published: (2019-11-01)

Discovery of Novel µ-Opioid Receptor Inverse Agonist from a Combinatorial Library of Tetrapeptides through Structure-Based Virtual Screening
by: Giulio Poli, et al.
Published: (2019-10-01)

The Discovery of Potentially Selective Human Neuronal Nitric Oxide Synthase (nNOS) Inhibitors: A Combination of Pharmacophore Modelling, CoMFA, Virtual Screening and Molecular Docking Studies
by: Guanhong Xu, et al.
Published: (2014-05-01)

Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer’s Diseases
by: Yan Guo, et al.
Published: (2020-01-01)

Synthesis and molecular docking studies of some 4-phthalimidobenzenesulfonamide derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors
by: Zeynep Soyer, et al.
Published: (2017-01-01)

Pharmacophore modeling and virtual screening for the discovery of new fatty acid amide hydrolase inhibitors
by: Dong-sheng Zhao, et al.
Published: (2011-06-01)

Inhibitors of Acetylcholinesterase and Butyrylcholinesterase Meet Immunity
by: Miroslav Pohanka
Published: (2014-06-01)

Pursuing the Complexity of Alzheimer’s Disease: Discovery of Fluoren-9-Amines as Selective Butyrylcholinesterase Inhibitors and <i>N</i>-Methyl-d-Aspartate Receptor Antagonists
by: Jan Konecny, et al.
Published: (2021-12-01)

Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking and Biological Evaluation for Identification of Potential Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors
by: Yunjiang Zhou, et al.
Published: (2019-11-01)

Hologram QSAR Models of 4-[(Diethylamino)methyl]-phenol Inhibitors of Acetyl/Butyrylcholinesterase Enzymes as Potential Anti-Alzheimer Agents
by: Carlos Rangel Rodrigues, et al.
Published: (2012-08-01)

Triterpene-Based Carboxamides Act as Good Inhibitors of Butyrylcholinesterase
by: Anne Loesche, et al.
Published: (2019-03-01)

Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer’s Disease
by: Minky Son, et al.
Published: (2019-02-01)

DEVELOPMENT OF BUTYRYLCHOLINESTERASE LIGANDS FOR THE IMAGING OF NEUROLOGICAL DISORDERS
by: Macdonald, Ian
Published: (2013)

Discovering Novel Alternaria solani Succinate Dehydrogenase Inhibitors by in Silico Modeling and Virtual Screening Strategies to Combat Early Blight
by: Sehrish Iftikhar, et al.
Published: (2017-11-01)

Synthesis and Biological Evaluation of Thiophene Derivatives as Acetylcholinesterase Inhibitors
by: Mai A. Galal, et al.
Published: (2012-06-01)

<i>O</i>-Substituted <i>N</i>(3)-benzyl analogs of vitamin B<sub>1</sub> as inhibitors of acetylcholinesterase or butyrylcholinesterase
by: Oleksandr Kobzar, et al.
Published: (2020-01-01)

Estudos de QSAR 3D para um conjunto de inibidores de butirilcolinesterase humana QSAR 3D studies of a series of human butyrylcholinesterase inhibitors
by: Humberto F. Freitas, et al.
Published: (2009-01-01)

Identification of Novel Src Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking and Molecular Dynamics Simulations
by: Yi Zhang, et al.
Published: (2020-09-01)

In silico Discovery of Novel FXa Inhibitors by Pharmacophore Modeling and Molecular Docking
by: Yinglan Pu, et al.
Published: (2017-06-01)

Discovery of Monoacylglycerol Lipase (MAGL) Inhibitors Based on a Pharmacophore-Guided Virtual Screening Study
by: Vibhu Jha, et al.
Published: (2021-12-01)

Development of potent reversible selective inhibitors of butyrylcholinesterase as fluorescent probes
by: Stane Pajk, et al.
Published: (2020-01-01)

Combining Virtual Screening Protocol and In Vitro Evaluation towards the Discovery of BACE1 Inhibitors
by: Judite R. M. Coimbra, et al.
Published: (2020-04-01)

Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer’s Disease: Computational Refining and Biochemical Evaluation
by: Nitin Chitranshi, et al.
Published: (2021-07-01)

3D QSAR studies, pharmacophore modeling, and virtual screening of diarylpyrazole–benzenesulfonamide derivatives as a template to obtain new inhibitors, using human carbonic anhydrase II as a model protein
by: Yeganeh Entezari Heravi, et al.
Published: (2017-01-01)

Based on the Virtual Screening of Multiple Pharmacophores, Docking and Molecular Dynamics Simulation Approaches toward the Discovery of Novel HPPD Inhibitors
by: Ying Fu, et al.
Published: (2020-08-01)

Application of ensemble pharmacophore-based virtual screening to the discovery of novel antimitotic tubulin inhibitors
by: Laura Gallego-Yerga, et al.
Published: (2021-01-01)

A Smartphone Camera Colorimetric Assay of Acetylcholinesterase and Butyrylcholinesterase Activity
by: Miroslav Pohanka, et al.
Published: (2021-03-01)

Dynamic Structure-Based Pharmacophore Model Development: A New and Effective Addition in the Histone Deacetylase 8 (HDAC8) Inhibitor Discovery
by: Keun Woo Lee, et al.
Published: (2011-12-01)